Retrospective Analysis of Hematological Parameters in Covid Positive Pregnancy
Article Sidebar
-
COVID19, Pregnancy, Neutrophil Lymphocyte Ratio, D-dimer
Abstract
The newly identified SARS-CoV-2 virus and its ongoing implicated COVID-19 pandemic started off as pneumonia of unknown aetiology in Wuhan, China, in December 2019. Certain laboratory values that may be considered deranged in non pregnant states are normal physiological changes in pregnancy. An understanding of the normal haematological and immunologic parameters in pregnancy is necessary for the interpretation of COVID-19 severity. Considering the COVID-19 infection is still new, little is known about the clinical course of the disease in pregnancy. This is a retrospective observational study undertaken in the Department of Obstetrics and Gynaecology, Saveetha Medical College Hospital, Chennai, India, from April to November 2020. Out of the 50 women in the study, 19 women were anaemic with haemoglobin <11, accounting for 38% of the study population. A neutrophil to lymphocyte ratio greater than 4.5 was observed in 44% of the population. Thrombocytopenia was present in 12% of the population. D-dimer greater than 1000 was found in 12% of the study population. All of our patients were asymptomatic, had good maternal and fetal outcomes even though derangement of inflammatory markers were noted. The immunological changes of pregnancy make pregnant women more susceptible to pathogens. Though our patients had instances suggestive of critical prognosis like an increased neutrophil-lymphocyte-ratio and affirmative acute phase reactants and inflammatory markers, they were asymptomatic (category BNH) and stable in room air. However, further analysis of laboratory parameters and their correlation to clinical scenarios in the second wave of COVID19 infection is warranted.
Full text article
References
Bergamaschi, G., Andreis, F. B. D., Aronico, N. 2021. Anemia in patients with Covid-19: pathogenesis and clinical significance. Clin Exp Med, 21:239–246.
CDC 2020. Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2. Updated on: 11.02.2020.
Chen, L., Li, Q., Zheng, D. 2020a. Clinical characteristics of pregnant women with COVID-19 in Wuhan, China. N Engl J Med, 382:100.
Chen, S., Liao, E., Cao, D., Gao, Y., Sun, G., Shao, Y. 2020b. Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia. J Med Virol, 92(9):1556–1561.
Cheng, B., Jiang, T., Zhang, L., Hu, R., Tian, J., Jiang, Y., Huang, B., Li, J., Wei, M., Yang, J., Ren, S., Wang, G. 2019. Clinical Characteristics of Pregnant Women with Coronavirus Disease. Open Forum Infectious Diseases, 7(8).
Giaxi, P., Maniatelli, E., Vivilaki, V. G. 2020. Evaluation of mode of delivery in pregnant women infected with COVID-19. European Journal of Midwifery, 4:28.
Gouez, L., Vivanti, A., Benhamou, A. J., Desconclois, D., Mercier, F. J. 2020. Thrombocytopenia in pregnant patients with mild COVID-19. International journal of obstetric anesthesia, 44:13–15.
Imran, M. M., Ahmed, U., Usman, U., Ali, M., Shaukat, A., Gul, N. 2021. Neutrophil/lymphocyte ratio-A marker of COVID-19 pneumonia severity. Int J Clin Pract, 75(4):13698.
Li, X., Liu, C., Mao, Z. 2020. Predictive values of neutrophil-to-lymphocyte ratio on disease severity and mortality in COVID-19 patients: a systematic review and meta-analysis. Crit Care, 24. Article Number-647.
Lokken, E. M., Huebner, E. M., Taylor, G. G., Hendrickson, S., Vanderhoeven, J., Kachikis, A. 2021. Disease severity, pregnancy outcomes, and maternal deaths among pregnant patients with severe acute respiratory syndrome coronavirus 2 infection in Washington State. American Journal of Obstetrics and Gynecology, 225(1):77e1–77e14.
Molberg, P., Johnson, C., Brown, T. S. 1994. Leukocytosis in labor: what are its implications? Family Practice Research Journal, 14(3):229–236.
Novel Coronavirus 2019. The American College of Obstetricians and Gynecologists. Update on: July 8, 2021.
Qiao, J. 2020. What are the risks of COVID-19 infection in pregnant women? The Lancet, 395(10226):760–762.
Royal College of obstetricians and gynaecologists 2020. Coronavirus (COVID19) Infection in pregnancy: Information for healthcare professionals. pages 1–68. Published on: 24 July 2020.
Syeda, S., Baptiste, C., Breslin, N., Gyamfi-Bannerman, C., Miller, R. 2020. The clinical course of COVID in pregnancy. Seminars in Perinatology, 44(7).
Vaught, J., Halscott, T. 2020. SMFM COVID-19 Task Force. Management Considerations for Pregnant Patients With COVID-19. Clinical recommendations. Soc Maternal Fetal Med, pages 1–33. Updated on: 01.07.21.
Waites, T., Gillian, C., Bell, S. 2019. Pregnancy Proteins and The Acute-Phase Response. Pregnancy Proteins in Animals, pages 195–212.
Yang, H., Sun, G., Tang, F. 2020. Clinical features and outcomes of pregnant women suspected of coronavirus disease 2019. J Infect, 81(1):40–44.
Yao, Y., Cao, J., Wang, Q. 2020. D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study. j intensive care, 8:49.
Yormaz, B., Ergun, D., Tulek, B., Ergun, R., Korez, K. M., Suerdem, M., Kanat, F. 2020. The evaluation of prognostic value of acute phase reactants in the COVID-19. Bratisl Lek Listy, 121(9):628–633.
Authors
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.